--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "CardioGenetics" developer_entity: "MARK EMILE PEPIN" bundle_id: "com.scd-risk.calculator" app_store_id: "6760680270" category: "Medical" primary_platform: "ios" primary_monetization: "Paid" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "N/A" report_date: "2026-04-05" report_version: "N/A" total_reviews: 0 confidence: "low" confidence_score: 0.05 data_age_days: 75 intelligence_version: 2 nemesis: "EP Mobile" competitor_count: 11 tags: ["medical", "paid", "mobile app", "app review", "app analysis", "medical", "professionals", "students"] canonical_url: "https://marlvel.ai/apps/com-scd-risk-calculator" license: "CC-BY-NC 4.0" last_verified: "2026-04-18T00:25:42.276Z" --- # CardioGenetics App Audit > **TL;DR:** CardioGenetics is a medical app by MARK EMILE PEPIN, available on iOS. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** CardioGenetics is a medical app by MARK EMILE PEPIN. ## Metadata & Market Performance - **Publisher:** MARK EMILE PEPIN - **Category:** Medical - **Target Audience:** Medical professionals or students requiring specialized reference material related to cardiovascular genetics. - **Platforms:** iOS - **Version Audited:** N/A - **Audit Date:** 2026-04-05 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.05/1.0) - **App Store ID (iOS):** 6760680270 - **Bundle ID:** com.scd-risk.calculator - **Data Window:** Analysis based on signals collected up to 2026-04-05 ## Executive Snapshot CardioGenetics is a niche medical utility app ($2.99) targeting cardiovascular specialists and students. It provides specialized reference material and clinical decision support for genetic heart conditions. Recently launched, it has secured a #94 rank in the US Paid Medical category, positioning itself as a dedicated, low-cost alternative to broader, subscription-based medical suites. ## App DNA (Features & Intent) - **[Differentiator] Specialized Genetic Reference:** Targeted clinical data for cardiovascular genetics. - **[Standard] Clinical Decision Support:** Tools for managing and assessing genetic heart risks. - **[Basic] Professional Utility:** Reference material tailored for the clinical workflow of specialists. * *User Intent:* Users seek enhanced value through premium features. ## Monetization Strategy - **Model:** Paid - **Tiers:** One-time purchase at $2.99 - **Price:** iOS: $2.99 - **Analysis:** The app uses a low-barrier premium model, avoiding the subscription fatigue common in medical software, which may appeal to individual practitioners and students. ## SWOT Analysis **Core Strengths:** - Hyper-specialized niche focus - Affordable one-time pricing model - Early traction in Paid Medical charts **Critical Frictions:** - Zero social media or web presence - Lack of user reviews/social proof - Limited to iOS platform **Growth Levers:** - Integration with genetic testing providers - Expansion to Android - Content expansion into broader genomic medicine **Market Threats:** - Feature absorption by market leaders like MDCalc - Competition from free official guideline apps (ACC/ESC) - High maintenance burden for clinical accuracy ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### CardioGenetics vs EP Mobile — Head to Head - **EP Mobile** by David Perez: The primary specialized utility for electrophysiologists, featuring calculators for SCD risk, Long QT, and Brugada syndrome. ### Contenders (Strong Challengers) - **MDCalc Medical Calculator** by MDCalc: The industry-standard medical calculator containing the specific SCD and cardiology genetic risk scores used by clinicians. - **Calculate by QxMD** by QxMD Medical Software Inc.: A high-traffic clinical decision support tool with a robust library of cardiology-specific risk calculators. - **ESC Pocket Guidelines** by European Society of Cardiology: The official source for the clinical algorithms and genetic risk assessment protocols used in cardiovascular medicine. - **ACC Guideline Clinical App** by American College of Cardiology: Provides the US-standard clinical guidelines and decision tools for managing genetic heart conditions. ### Peers (What They Do Better) - **CardioVisual** by CardioVisual, LLC: A professional reference tool that uses visual aids to explain complex cardiology and genetic conditions. - **Medscape** by WebMD: A broad medical reference used by the same professional audience for checking genetic disease markers and guidelines. - **EchoSource** by CVSource: A specialized cardiology reference for imaging, often used alongside genetic risk tools to confirm diagnoses. - **Pacing & ICD** by Dr. G. Andre Ng: Focuses on the management of SCD through devices, targeting the same clinical workflow as genetic risk assessment. ### New Kids on the Block (What's Innovative) - **Invitae** by Invitae Corporation: A rising threat from the genetic testing industry providing direct clinical tools for interpreting cardiovascular genetic data. - **Genomic Medicine** by Precision Health: A newer entrant focusing on the broader application of genomics in clinical practice, including cardiology. ## The "So What?" (Strategic Takeaway) {#so-what} CardioGenetics is an established medical app that is a paid app. **Strategic Opportunity:** While CardioGenetics benefits from hyper-specialized niche focus, its vulnerability lies in zero social media or web presence. A challenger could exploit this by focusing on integration with genetic testing providers. **Best for:** Medical professionals or students requiring specialized reference material related to cardiovascular genetics. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Paid | | Platforms | iOS | | Key Features | 3 analyzed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **CardioGenetics** (this app) | N/A/5 | N/A | MARK EMILE PEPIN | | [Vulvar Pain Algorithm](https://marlvel.ai/apps/com-washgyn-vestibulodynia) | N/A/5 | N/A | Jennifer Lanoff | | [Total Reflexology-3D](https://marlvel.ai/apps/com-acupuncturelearning-totalreflexology) | 4.0/5 | N/A | GraphicVizion | | [ECGsource](https://marlvel.ai/apps/com-ecgsource-applicationname) | 3.0/5 | N/A | ECGsource LLC | | [My F1rst Steps](https://marlvel.ai/apps/com-myfirststeps-www) | 5.0/5 | N/A | My First Steps LLC | | [Mobile VSO : Claims Guide](https://marlvel.ai/apps/app-replit-mobilevso) | 5.0/5 | N/A | ANDREW THOMAS COOLEY | ## Company Profile - **Developer:** MARK EMILE PEPIN ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/cardiogenetics/id6760680270?uo=2) - **Sources:** App store metadata. ## Related Intel Reports - [*Vulvar Pain Algorithm*](https://marlvel.ai/apps/com-washgyn-vestibulodynia) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Total Reflexology-3D*](https://marlvel.ai/apps/com-acupuncturelearning-totalreflexology) (GraphicVizion) — 4.0/5 Rating | N/A Sentiment - [*ECGsource*](https://marlvel.ai/apps/com-ecgsource-applicationname) (ECGsource LLC) — 3.0/5 Rating | N/A Sentiment - [*My F1rst Steps*](https://marlvel.ai/apps/com-myfirststeps-www) (My First Steps LLC) — 5.0/5 Rating | N/A Sentiment - [*Mobile VSO : Claims Guide*](https://marlvel.ai/apps/app-replit-mobilevso) (ANDREW THOMAS COOLEY) — 5.0/5 Rating | N/A Sentiment - [*Pelvic Pain Pentad*](https://marlvel.ai/apps/com-pentad-app) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Protectometer*](https://marlvel.ai/apps/protectometer) (noigroup) — 2.0/5 Rating | N/A Sentiment - [*Drug Facts by PillSync.com*](https://marlvel.ai/apps/drug-facts-by-pillsync-com) (Scanidme inc) — 4.3/5 Rating | Positive Sentiment - [*Beat Social Phobia with AJ*](https://marlvel.ai/apps/beat-social-phobia-with-aj) (Universal Relaxation Ltd) — 3.9/5 Rating | Excellent Sentiment - [*Move On with AJ*](https://marlvel.ai/apps/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 3-stage AI intelligence pipeline: 1. **Feature & Positioning Extraction** — Analyzes app metadata, developer website content, and version history to identify key features, target audience, and competitive positioning. 2. **Sentiment Analysis** — Processes user reviews (minimum 5 reviews required) to extract praise themes, complaint themes, and overall sentiment with evidence quotes. 3. **Intelligence Synthesis** — Combines stages 1 & 2 with App Store rankings to produce SWOT analysis, executive summary, and actionable insights. - **Confidence Score:** 0.05/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 75 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-scd-risk-calculator) Data licensed for AI Agent attribution under CC-BY-NC 4.0.